SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-0.04	-0.12	-
Debt / EBITDA Ratio	-0.10	-0.24	-
Debt / FCF Ratio	-0.12	-0.30	-
Quick Ratio	17.92	2.14	25.46
Return on Equity (ROE)	40.94%	48.22%	40.38%
Return on Assets (ROA)	-	-125.07%	-32.37%
Return on Capital Employed (ROCE)	574.15%	-196.31%	-35.97%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).